常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-19.00/-0.86
|
|
企業價值
51.23M
|
| 資產負債 |
|
每股賬面淨值
-0.87
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.58
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| NovaBay Pharmaceuticals Inc is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, it seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight. |

1.945 
